Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1473763

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1473763

Shock Wave Therapy Devices Market - By Technology (Focused {EMSG, EHSG, PSG}, Radial or Ballistic, Combined), Application (Orthopedic, Cardiology, Urology), Type (Portable, Fixed), End-use (Hospitals, Diagnostic Labs, ASC) - Global Forecast, 2024 - 2032

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Shock Wave Therapy Devices Market size is expected to grow at 4.9% CAGR during 2024-2032, driven by technological advancements, rising healthcare expenditure and investments in healthcare infrastructure along with rising regulatory approvals and reimbursement policies. Of late, the prevalence of musculoskeletal disorders and chronic conditions, such as tendinopathies, plantar fasciitis, and osteoarthritis is significantly increasing. According to the Institute for Health Metrics & Evaluation in 2023, cases of other musculoskeletal disorders are expected to surge by 115% from 2020 to 2050, reaching an estimated 1060 million prevalent cases by 2050.

With aging population and sedentary lifestyles becoming more prevalent globally, the incidence of these conditions is on the rise. Additionally, sports-related injuries are contributing to the growing burden of musculoskeletal ailments. Consequently, there is heightened demand for effective non-invasive treatment options like shock wave therapy devices to offer patients relief from pain and improve their quality of life. This increasing demand is underscoring the importance of innovative medical technologies in addressing the healthcare needs of individuals suffering from musculoskeletal disorders and chronic conditions, thereby inducing industry growth.

The shock wave therapy devices market is classified into technology, application, type, end-use and region.

Based on application, the industry size from the cardiology segment is set to attain 4.5% CAGR through 2032, as shock wave therapy has gained traction as an alternative treatment modality for refractory angina and peripheral arterial disease. The non-invasive nature of shock wave therapy makes it an attractive option for patients who are not suitable candidates for traditional revascularization procedures. As a result, cardiologists are incorporating shock wave therapy devices into their treatment protocols.

By type segmentation, the portable shock wave therapy devices market is poised to grow at 5.1% CAGR from 2024 to 2032. Portable devices offer the advantage of flexibility and convenience, allowing healthcare providers to administer shock wave therapy in various clinical settings, including outpatient clinics, sports medicine facilities, and rehabilitation centers. The portability of these devices is also enhancing the patient access to shock wave therapy treatments, contributing to the segment growth.

Asia Pacific shock wave therapy devices market is anticipated to grow at an unprecedented pace at 5.8% CAGR till 2032, driven by large population base, coupled with the increasing prevalence of musculoskeletal disorders and cardiovascular diseases. Moreover, the growing healthcare infrastructure and rising healthcare expenditure in countries, such as China, India, and Japan will further bolster market growth in the region.

Product Code: 3189

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of musculoskeletal disorders
      • 3.2.1.2 Technological advancements in shock wave therapy devices
      • 3.2.1.3 Rising number of sports injuries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of shock wave therapy devices
      • 3.2.2.2 Limited reimbursement policies
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Focused shockwave generation
    • 5.2.1 Electrohydraulic shock wave generation (EHSG)
    • 5.2.2 Piezoelectric shock wave generation (PSG)
    • 5.2.3 Electromagnetic shock wave generation (EMSG)
  • 5.3 Radial or ballistic shock wave generation
  • 5.4 Combined shock wave generation

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Orthopedic
  • 6.3 Cardiology
  • 6.4 Urology
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Portable
  • 7.3 Fixed

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Diagnostic laboratories
  • 8.4 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Boston Scientific Corporation
  • 10.2 BTL Corporate
  • 10.3 Becton, Dickinson and Company (C. R. Bard, Inc.)
  • 10.4 Dornier MedTech.
  • 10.5 Edaptms TMS
  • 10.6 EMS DolorClast
  • 10.7 Lumenis Ltd.
  • 10.8 Olympus Corporation
  • 10.9 Siemens Healthineers AG
  • 10.10 Zimmer MedizinSysteme GmbH
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!